CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-07 | GILMAN STEVEN C Director | Sale | −4,567 | $3.32 | $15K | 47,997 |
| 2021-06-02 | Wolf Myles Director | Grant or award | +13,700 | 23,981 | ||
| 2021-06-02 | Wolf Myles Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2021-06-02 | Smith Cynthia Director | Grant or award | +13,700 | 51,533 | ||
| 2021-06-02 | Smith Cynthia Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2021-06-02 | ROGERS MICHAEL W Director | Grant or award | +13,700 | 52,329 | ||
| 2021-06-02 | ROGERS MICHAEL W Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2021-06-02 | Heffernan Michael Thomas Director | Grant or award | +13,700 | 48,586 | ||
| 2021-06-02 | Heffernan Michael Thomas Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2021-06-02 | GILMAN STEVEN C Director | Grant or award | +13,700 | 52,564 | ||
| 2021-06-02 | GILMAN STEVEN C Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2021-06-02 | ADAMS ADRIAN Director | Grant or award | +13,700 | 91,100 | ||
| 2021-06-02 | ADAMS ADRIAN Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2021-04-01 | Faulkingham Dell SVP, CCO | Sale | −952 | $3.40 | $3K | 137,025 |
| 2021-04-01 | Spellman David A SVP, CFO and Treasurer | Sale | −790 | $3.40 | $3K | 76,802 |
| 2021-04-01 | Hadas Nicole R. SVP, Chief Legal Officer | Sale | −1,060 | $3.40 | $4K | 272,303 |
| 2021-04-01 | Dahan Michel SVP, Chief Operating Officer | Sale | −1,211 | $3.40 | $4K | 265,550 |
| 2021-04-01 | Butler John P. CEO and President | Sale | −4,109 | $3.40 | $14K | 1,152,153 |
| 2021-04-01 | Burke Steven Keith SVP, Chief Medical Officer | Sale | −1,081 | $3.40 | $4K | 170,761 |
| 2021-03-16 | Spellman David A SVP, CFO and Treasurer | Grant or award | +7,592 | 77,592 |
Page 13 of 21 · 405 trades